Hopital Nord de Marseille
Marseille 13015
1 studies enrolling now · 3 studies all time
What they study most
Advanced Non Small Cell Lung Cancer, Advanced Non-Small Cell Lung Cancer, Idiopathic Pulmonary Fibrosis (IPF), Metastatic Non Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Studies at this site
- Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 — Recruiting now
- Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation — Running, not enrolling
- A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) — Completed